GlobeNewswire Inc.··NaIpsen's First-in-Class Corabotase Shows Promise in Phase II Glabellar Lines Study
Ipsen's experimental corabotase demonstrates rapid onset and sustained efficacy in Phase II trial for facial wrinkles, advancing toward Phase III testing.
IPSEYPhase II trialaesthetic medicine